mexB Efflux Pump Gene Expression, Activity and Biofilm Formation in Clinical Isolates of Pseudomonas Aeruginosa
NCT07469436 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2026-03-17
Summary
1. Detection of expression level of mexB efflux pump gene in multidrug resistant clinical isolates of Pseudomonas aeruginosa by real time PCR(QRT-PCR).
2. Phenotypic detection of efflux pump activity in multidrug resistant clinical isolates of Pseudomonas aeruginosa.
3. Phenotypic detection of biofilm formation and its degree (strong-moderate-weak) in multidrug resistant clinical isolates of Pseudomonas aeruginosa.
4. Relationship between expression level of mexB efflux pump gene and degree of biofilm formation in multidrug resistant clinical isolates of Pseudomonas aeruginosa.
Conditions
- Pseudomonas Aeroginosa
Interventions
- GENETIC
-
Real time PCR
Clinical isolates of Pseudomonas aeruginosa will undergo RNA extraction followed by cDNA (complementary DNA) synthesis. Quantitative real-time PCR will be performed using specific primers for the mexB efflux pump gene, and SYBR Green will be used to quantify gene expression. Housekeeping genes (e.g., rpoD or 16S rRNA) will serve as internal controls. The procedure allows precise quantification of mexB expression levels in each isolate.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Assiut University · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2027-12-31
- Completion
- 2028-01-31
More Related Trials
-
Detection of Efflux Pump Genes Mediating Ciprofloxacin Resistance in Staphylococcus Aureus Isolates in Sohag University Hospitals
NCT05828550 ·Status: COMPLETED ·Phase: NA
-
Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection
NCT07429162 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
NCT07228702 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia
NCT04597242 ·Status: NO_LONGER_AVAILABLE
-
Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives
NCT01184339 ·Status: COMPLETED
-
Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers
NCT00778388 ·Status: COMPLETED ·Phase: PHASE1
-
Development and Implementation of Mobile Antibiograms to Optimize Empirical Antibiotic Prescriptions Among Prescribers in Tertiary Hospitals in Tanzania
NCT07393308 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
NCT04310930 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis
NCT07129629 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia
NCT06695832 ·Status: ACTIVE_NOT_RECRUITING
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
mNGS Was Applied to the Study of Pathogen Identification, Precision Medication and Efficacy Evaluation of Infected Patients
NCT04310657 ·Status: UNKNOWN ·Phase: NA
-
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
NCT04677543 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
NCT01671358 ·Status: COMPLETED
-
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
NCT01498419 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
NCT01049438 ·Status: COMPLETED ·Phase: NA
-
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
NCT07213765 ·Status: RECRUITING ·Phase: PHASE4
-
Impact MRSA -PCR on Patient Management
NCT03096405 ·Status: COMPLETED
-
Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform
NCT04345939 ·Status: UNKNOWN
-
Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease
NCT07372781 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
NCT01222832 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease
NCT05824988 ·Status: RECRUITING
-
Silver Nanoparticles in Multidrug Resistant Bacteria
NCT04431440 ·Status: COMPLETED
-
Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
NCT01594827 ·Status: COMPLETED ·Phase: PHASE2